Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PARO Robots commercializes PARO, an interactive therapeutic robot designed for healthcare and elder-care settings as a non-pharmacological intervention. The product is a baby harp seal-shaped robotic companion originally developed through research led by AIST and is used in hospitals, long-term care, dementia care, and related settings to promote calming, engagement, and social interaction. PARO has been described as an FDA Class II biofeedback medical device in the United States and is marketed for conditions such as anxiety, depression, loneliness, PTSD, and cognitive disorders. The company appears to operate primarily as a commercial medical-device and healthcare robotics business rather than a drug-development biotech company. Its core business is centered on distribution, commercialization, and support of the PARO therapeutic robot rather than maintaining a traditional pharmaceutical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PARO Robots.